These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10965168)

  • 21. Subacute demyelinating disease in an adult (diffuse-disseminated sclerosis). Electron microscopic findings.
    Andrews JM; Cancilla PA
    Bull Los Angeles Neurol Soc; 1973 Apr; 38(2):49-59. PubMed ID: 4349856
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations.
    Eisendle K; Linder D; Ratzinger G; Zelger B; Philipp W; Piza H; Fritsch P; Schmuth M
    J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S47-9. PubMed ID: 18191707
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of xanthoma disseminatum with simvastatin.
    Lee EH; Kang TW; Kim SC
    J Dermatol; 2011 Oct; 38(10):1015-7. PubMed ID: 21592199
    [No Abstract]   [Full Text] [Related]  

  • 24. Xanthoma disseminatum with respiratory tract involvement and fatal outcome.
    Davies CW; Marren P; Juniper MC; Gray W; Wojnorowska F; Benson MK
    Thorax; 2000 Feb; 55(2):170-2. PubMed ID: 10639538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An autopsy case of chronic disseminated encephalomyelitis complicated by Behçet's syndrome, with special reference to the demyelinating diseases.
    Totsuka S; Matsumoto Y; Tanikawa K
    Folia Psychiatr Neurol Jpn; 1965; 19(1):17-28. PubMed ID: 5899884
    [No Abstract]   [Full Text] [Related]  

  • 26. Xanthoma disseminatum in an infant with skeletal and marrow involvement.
    Calverly DC; Wismer J; Rosenthal D; deSa D; Barr RD
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):61-5. PubMed ID: 7743240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of the ground substance on the extracellular water of normal and edematous human brain: focal edema and the demyelinating diseases, including multiple sclerosis.
    Feigin I; Budzilovich GN
    J Neuropathol Exp Neurol; 1980 Jan; 39(1):13-29. PubMed ID: 7359171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview.
    Campero M; Campero S; Guerrero J; Aouba A; Castro A
    Dermatology; 2016; 232(2):171-6. PubMed ID: 26741816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthoma disseminatum in a child with cranial bone involvement.
    Yağci B; Varan A; Altinok G; Söylemezoğlu F; Cila A; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2008 Apr; 30(4):310-2. PubMed ID: 18391701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xanthoma disseminatum with atypical histochemical features.
    Patel T; Slater DN; Hepburn NC; Gawkrodger DJ
    Clin Exp Dermatol; 2010 Jul; 35(5):555-6. PubMed ID: 20236289
    [No Abstract]   [Full Text] [Related]  

  • 31. Xanthoma disseminatum: a red herring xanthomatosis.
    Mahajan VK; Sharma AL; Chauhan PS; Mehta KS; Sharma V; Sharma S
    Indian J Dermatol Venereol Leprol; 2013; 79(2):253-4. PubMed ID: 23442474
    [No Abstract]   [Full Text] [Related]  

  • 32. Xanthoma disseminatum: a case with hepatic involvement, diabetes insipidus and type IIb hyperlipidaemia.
    Woollons A; Darley CR
    Clin Exp Dermatol; 1998 Nov; 23(6):277-80. PubMed ID: 10233626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disseminated xanthosiderohistiocytosis with cardiac involvement and monoclonal gammapathy].
    Lazrak K; Machet MC; Forest JL; Machet L; Lorette G; Pasquiou C
    Ann Dermatol Venereol; 1993; 120(12):904-6. PubMed ID: 8074353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-demyelinating ophthalmo-encephalomyelitis with a chronic evolution in bursts].
    Vuia O; Seitan I; Alexianu M
    Acta Neurol Psychiatr Belg; 1967 Jul; 67(7):567-82. PubMed ID: 4964295
    [No Abstract]   [Full Text] [Related]  

  • 35. Xanthoma Disseminatum in a Young Patient with Diabetes Insipidus.
    Hui Y; Zhang CZ; Chen J; Kong QT; Chen H; Du X; Sang H
    Pediatr Dermatol; 2017 May; 34(3):e144-e145. PubMed ID: 28523884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthoma disseminatum with neurological involvement and optic atrophy: improvement with cladribine.
    Patra S; Bhatia S; Khaitan BK; Bhari N
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31118172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xanthoma disseminatum associated with inflammatory arthritis and synovitis--a rare association.
    Gupta P; Khandpur S; Vedi K; Singh MK; Walia R
    Pediatr Dermatol; 2015; 32(1):e1-4. PubMed ID: 25496014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal manifestations in a patient with xanthoma disseminatum (non-langerhans cell histiocytosis).
    Konstantinidis L; Laffitte E; Wasem YM; Balaskas K; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2011 Apr; 228(4):379-80. PubMed ID: 21484660
    [No Abstract]   [Full Text] [Related]  

  • 39. Xanthoma disseminatum effectively treated with 2-chlorodeoxyadenosin (cladribine): a Chinese case series and mini review of the literature.
    Tuan H; Kang L; Zhou EY; Chen D; Liu D; Shu D; Bi Z; Zhao Y
    Eur J Dermatol; 2019 Oct; 29(5):538-539. PubMed ID: 31591984
    [No Abstract]   [Full Text] [Related]  

  • 40. Demyelinating peripheral neuropathy associated with hemophagocytic lymphohistiocytosis. An immuno-electron microscopic study.
    De Armas R; Sindou P; Gelot A; Routon MC; Ponsot G; Vallat JM
    Acta Neuropathol; 2004 Oct; 108(4):341-4. PubMed ID: 15243760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.